Molina Healthcare, Inc. (NYSE:MOH) Holdings Cut by National Bank of Canada FI

National Bank of Canada FI cut its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 16.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,790 shares of the company’s stock after selling 5,330 shares during the quarter. National Bank of Canada FI’s holdings in Molina Healthcare were worth $7,797,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Versant Capital Management Inc boosted its position in Molina Healthcare by 83.1% during the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock valued at $47,000 after purchasing an additional 74 shares during the period. Wingate Wealth Advisors Inc. bought a new stake in Molina Healthcare in the fourth quarter valued at $52,000. EverSource Wealth Advisors LLC boosted its holdings in shares of Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock valued at $57,000 after acquiring an additional 88 shares during the period. Harvest Fund Management Co. Ltd grew its position in shares of Molina Healthcare by 895.0% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company’s stock worth $58,000 after acquiring an additional 179 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Molina Healthcare by 337.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company’s stock worth $58,000 after acquiring an additional 155 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now owns 17,375 shares in the company, valued at $5,235,608.75. The trade was a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.10% of the stock is currently owned by company insiders.

Molina Healthcare Stock Performance

Shares of MOH opened at $347.26 on Friday. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $383.58. The stock has a market capitalization of $18.99 billion, a P/E ratio of 17.00, a P/E/G ratio of 1.06 and a beta of 0.56. The firm’s 50 day moving average is $306.76 and its 200-day moving average is $308.73. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. Equities research analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Analysts Set New Price Targets

MOH has been the subject of a number of analyst reports. Stephens reissued an “equal weight” rating and set a $345.00 target price on shares of Molina Healthcare in a research note on Thursday, February 6th. Truist Financial decreased their price objective on Molina Healthcare from $370.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, February 19th. Barclays cut their target price on Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating on the stock in a research note on Friday, February 7th. Mizuho decreased their price target on Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a $350.00 price objective (down from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Seven analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Molina Healthcare has an average rating of “Moderate Buy” and an average price target of $348.75.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.